Quarterly report pursuant to Section 13 or 15(d)

Subsequent Event

Subsequent Event
6 Months Ended
Jun. 30, 2021
Subsequent Events [Abstract]  
Subsequent Event

10. Subsequent Event


In August 2021, the Company entered into an agreement with a contract manufacturing organization for the purchase of plasmids to be used in vector manufacturing for a total cost of $1,100, expected to be incurred during 2021 and 2022.